These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies. Angeles MA; Mallet E; Rouanet P; Cabarrou B; Méeus P; Lambaudie E; Foucher F; Narducci F; Loaec C; Gouy S; Guyon F; Marchal F; Gladieff L; Martínez-Gómez C; Migliorelli F; Martinez A; Ferron G Int J Gynecol Cancer; 2020 Feb; 30(2):233-240. PubMed ID: 31796531 [TBL] [Abstract][Full Text] [Related]
3. Pelvic exenterations for gynecological malignancies: a study of 36 cases. Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477 [TBL] [Abstract][Full Text] [Related]
4. Incidence and management of major urinary complications after pelvic exenteration for gynecological malignancies. Bladou F; Houvenaeghel G; Delpéro JR; Guérinel G J Surg Oncol; 1995 Feb; 58(2):91-6. PubMed ID: 7844989 [TBL] [Abstract][Full Text] [Related]
5. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Berek JS; Howe C; Lagasse LD; Hacker NF Gynecol Oncol; 2005 Oct; 99(1):153-9. PubMed ID: 16054678 [TBL] [Abstract][Full Text] [Related]
6. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece. Haidopoulos D; Pergialiotis V; Aggelou K; Thomakos N; Alexakis N; Stamatakis E; Rodolakis A Surg Oncol; 2022 Mar; 40():101702. PubMed ID: 35065392 [TBL] [Abstract][Full Text] [Related]
7. Urinary diversion after pelvic exenteration for gynecologic malignancies. Martínez-Gómez C; Angeles MA; Martinez A; Malavaud B; Ferron G Int J Gynecol Cancer; 2021 Jan; 31(1):1-10. PubMed ID: 33229410 [TBL] [Abstract][Full Text] [Related]
8. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution. Jäger L; Nilsson PJ; Rådestad AF Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096 [TBL] [Abstract][Full Text] [Related]
9. [Preliminary experience with the Miami type ileocolonic urinary reservoir in the practice of oncologic gynecology]. Sánchez-Valdivieso E; González Enciso A; Herrera Gómez A; Chávez Montes de Oca V; Muñóz González D Arch Esp Urol; 2001 May; 54(4):327-33. PubMed ID: 11455766 [TBL] [Abstract][Full Text] [Related]
10. Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignancies. Urh A; Soliman PT; Schmeler KM; Westin S; Frumovitz M; Nick AM; Fellman B; Urbauer DL; Ramirez PT Gynecol Oncol; 2013 Jun; 129(3):580-5. PubMed ID: 23480870 [TBL] [Abstract][Full Text] [Related]
11. Pelvic exenteration for primary and recurrent gynaecological malignancies. de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559 [TBL] [Abstract][Full Text] [Related]
12. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients. Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266 [TBL] [Abstract][Full Text] [Related]
13. Surgical results of pelvic exenteration in the treatment of gynecologic cancer. Petruzziello A; Kondo W; Hatschback SB; Guerreiro JA; Filho FP; Vendrame C; Luz M; Ribeiro R World J Surg Oncol; 2014 Sep; 12():279. PubMed ID: 25200866 [TBL] [Abstract][Full Text] [Related]